To validate the expression of KANK2 in tumors, we performed immunohistochemistry (IHC), Western blotting (WB) and qPCR analysis in KIRC, HCC and PAAD, respectively. The gene discussed is KANK2; the disease is pancreatic adenocarcinoma.